Sun Yat-sen University (SYSU), Zhengzhou University, Tianjin Medical University - Tianjin Cancer Institute, Huazhong University of Science and Technology, Nanjing Medical University, University of Ulsan - Asan Medical Center, Macquarie University, Central South University - Hunan Cancer Hospital, Seoul National University, Central South University, Wuhan University, Monash University, Fudan University - Department of Medical Oncology, Yeshiva University - Montefiore/Einstein Center for Cancer Care, China Medical University - Cancer Stem Cell and Translation Medicine Lab, Fujian Medical University - Fujian Cancer Hospital, Seoul National University - Department of Internal Medicine, Chinese Academy of Medical Sciences - National Cancer Center, Shanghai Jiao Tong University (SJTU), PASO Medical, Mary Crowley Cancer Research Center, Sichuan Cancer Hospital, Sun Yat-sen University (SYSU), Shanxi Cancer Hospital, Huazhong University of Science and Technology - Hubei Cancer Hospital, Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. and Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation

Sun Yat-Sen University (SYSU), Zhongshan School of Medicine, Sun Yat-Sen Memorial Hospital, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, University of Electronic Science and Technology of China (UESTC) - School of Medicine, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Centre, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Centre, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Centre, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Sun Yat-sen University (SYSU) - Guangdong Key Laboratory of Liver Disease Research, First People’s Hospital of Foshan, Foshan Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU) - Department of Ultrasound, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Centre, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Centre, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Centre, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Government of the People's Republic of China - Department of Breast Cancer, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine and Sun Yat-sen University (SYSU) - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation